Is Cognex Corporation (CGNX) overvalued? · P/E 76, rev $559.7M
Cognex Corporation (CGNX) is a scientific & technical instruments company listed on NASDAQ.
This page asks whether Cognex Corporation (CGNX) looks expensive on cached numbers — not a short thesis.
Latest reported CGNX revenue for 2026-07-05 was $559.7M. Net income was $124.5M. CGNX currently screens at market cap $10.78B and trailing P/E 76.2.
CGNX currently screens at market cap $10.78B and trailing P/E 76.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CGNX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CGNX stock page for the full model, not this heading.
Not investment advice.